Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Dearnaley

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
BJU International|September 14, 2007
Additional treatment for pT3 prostate cancer: now, later or neverDavid P Dearnaley
The Lancet. Oncology|February 7, 2015
Hypofractionated radiotherapy in prostate cancerDavid P Dearnaley
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
In regard to "The return of the snake oil salesman" (IJROBP 2003;55:561-562, and 56:1507-1508)David P Dearnaley
Future Oncology (London, England)|August 19, 2021
Relugolix, an oral gonadotropin-releasing hormone antagonist for the treatment of prostate cancerDaniel J George, David P Dearnaley
Frontiers of Radiation Therapy and Oncology|January 5, 2002
Prostate cancer--the Royal Marsden conformal experienceChristopher M Nutting, David P Dearnaley
Expert Review of Anticancer Therapy|July 11, 2009
Additional therapy for high-risk prostate cancer treated with surgery: what is the evidence?Scott C Morgan, David P Dearnaley
The Lancet. Oncology|March 4, 2021
Intermediate clinical endpoints in localised prostate cancerAlison C Tree, David P Dearnaley, Emma Hall
Current Oncology Reports|March 27, 2017
The Role of Hypofractionated Radiotherapy in Prostate CancerLinus C Benjamin, Alison C Tree, David P Dearnaley
Cancer Management and Research|December 5, 2015
Rationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?Julia R Murray, Helen A McNair, David P Dearnaley
European Urology|March 8, 2016
Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30Alison C Tree, Nicholas J van As, David P Dearnaley
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
BJU International|September 14, 2007
Additional treatment for pT3 prostate cancer: now, later or neverDavid P Dearnaley
The Lancet. Oncology|February 7, 2015
Hypofractionated radiotherapy in prostate cancerDavid P Dearnaley
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
In regard to "The return of the snake oil salesman" (IJROBP 2003;55:561-562, and 56:1507-1508)David P Dearnaley
Future Oncology (London, England)|August 19, 2021
Relugolix, an oral gonadotropin-releasing hormone antagonist for the treatment of prostate cancerDaniel J George, David P Dearnaley
Frontiers of Radiation Therapy and Oncology|January 5, 2002
Prostate cancer--the Royal Marsden conformal experienceChristopher M Nutting, David P Dearnaley
Expert Review of Anticancer Therapy|July 11, 2009
Additional therapy for high-risk prostate cancer treated with surgery: what is the evidence?Scott C Morgan, David P Dearnaley
The Lancet. Oncology|March 4, 2021
Intermediate clinical endpoints in localised prostate cancerAlison C Tree, David P Dearnaley, Emma Hall
Current Oncology Reports|March 27, 2017
The Role of Hypofractionated Radiotherapy in Prostate CancerLinus C Benjamin, Alison C Tree, David P Dearnaley
Cancer Management and Research|December 5, 2015
Rationale and development of image-guided intensity-modulated radiotherapy post-prostatectomy: the present standard of care?Julia R Murray, Helen A McNair, David P Dearnaley
European Urology|March 8, 2016
Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30Alison C Tree, Nicholas J van As, David P Dearnaley
Pageof 15